ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Bills To Lift $50 Cap On Mammography Will Be Introduced

February 10, 1989

In Brief: NCI Would Get Extra $115 Million Over Three Years Under Budget Amendment By Alabama Senator

June 4, 1982

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

September 28, 1979

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985